| Title : Two pharmacologically distinct components of nicotinic receptor-mediated rubidium efflux in mouse brain require the beta2 subunit - Marks_1999_J.Pharmacol.Exp.Ther_289_1090 |
| Author(s) : Marks MJ , Whiteaker P , Calcaterra J , Stitzel JA , Bullock AE , Grady SR , Picciotto MR , Changeux JP , Collins AC |
| Ref : Journal of Pharmacology & Experimental Therapeutics , 289 :1090 , 1999 |
| Abstract : Marks_1999_J.Pharmacol.Exp.Ther_289_1090 |
| ESTHER : Marks_1999_J.Pharmacol.Exp.Ther_289_1090 |
| PubMedSearch : Marks_1999_J.Pharmacol.Exp.Ther_289_1090 |
| PubMedID: 10215692 |
Marks MJ, Whiteaker P, Calcaterra J, Stitzel JA, Bullock AE, Grady SR, Picciotto MR, Changeux JP, Collins AC (1999)
Two pharmacologically distinct components of nicotinic receptor-mediated rubidium efflux in mouse brain require the beta2 subunit
Journal of Pharmacology & Experimental Therapeutics
289 :1090
Marks MJ, Whiteaker P, Calcaterra J, Stitzel JA, Bullock AE, Grady SR, Picciotto MR, Changeux JP, Collins AC (1999)
Journal of Pharmacology & Experimental Therapeutics
289 :1090